Hypothyroidism News and Research

RSS
Hypothyroidism occurs when the thyroid gland does not produce enough thyroid hormone to meet the body’s needs. Without enough thyroid hormone, many of the body’s functions slow down. About 5 percent of the U.S. population has hypothyroidism. Women are much more likely than men to develop hypothyroidism.
Hyperthyroidism and severe hypothyroidism associated with overall unhealthy status, shorter lifespan

Hyperthyroidism and severe hypothyroidism associated with overall unhealthy status, shorter lifespan

Study examines the utility of thyroid function screening in youth with mood and anxiety disorders

Study examines the utility of thyroid function screening in youth with mood and anxiety disorders

Obstructive sleep apnea may be one reason for treatment-resistant depression

Obstructive sleep apnea may be one reason for treatment-resistant depression

Baby socks contain traces of bisphenol A and parabens, study finds

Baby socks contain traces of bisphenol A and parabens, study finds

Vegans are often deficient in these four nutrients

Vegans are often deficient in these four nutrients

Dogs with hypothyroidism or that take omega-3 fatty acid may have lower risk of T-zone lymphoma

Dogs with hypothyroidism or that take omega-3 fatty acid may have lower risk of T-zone lymphoma

Study shows how some autoimmune diseases are more closely related than others

Study shows how some autoimmune diseases are more closely related than others

Castration-resistant metastatic prostate cancer responds to combination of immune checkpoint inhibitors

Castration-resistant metastatic prostate cancer responds to combination of immune checkpoint inhibitors

Vanderbilt study strengthens link between thyroid function and atrial fibrillation

Vanderbilt study strengthens link between thyroid function and atrial fibrillation

Combination of Opdivo and Yervoy shows four-year survival benefits in patients with advanced melanoma

Combination of Opdivo and Yervoy shows four-year survival benefits in patients with advanced melanoma

Merck presents MK-1454 Phase 1 data for treatment of advanced solid tumors or lymphomas

Merck presents MK-1454 Phase 1 data for treatment of advanced solid tumors or lymphomas

Merck presents KEYNOTE-057 trial results for patients with high-risk non-muscle invasive bladder cancer

Merck presents KEYNOTE-057 trial results for patients with high-risk non-muscle invasive bladder cancer

Immunotherapy increases survival in some patients with metastatic triple negative breast cancer

Immunotherapy increases survival in some patients with metastatic triple negative breast cancer

Lab study shows effectiveness of potential therapy for treatment-resistant hypothyroidism

Lab study shows effectiveness of potential therapy for treatment-resistant hypothyroidism

Doctor to the stars disciplined over use of controversial menopause therapy

Doctor to the stars disciplined over use of controversial menopause therapy

Standard hypothyroidism treatment inadequate in controlling crucial aspects of the condition

Standard hypothyroidism treatment inadequate in controlling crucial aspects of the condition

Two thyroid medications recalled by FDA

Two thyroid medications recalled by FDA

CNDA approves KEYTRUDA for treatment of advanced melanoma

CNDA approves KEYTRUDA for treatment of advanced melanoma

Phase 3 study of KEYTRUDA monotherapy meets primary endpoint

Phase 3 study of KEYTRUDA monotherapy meets primary endpoint

Ferring announces FDA approval of ZOMACTON for injection in four new pediatric indications

Ferring announces FDA approval of ZOMACTON for injection in four new pediatric indications